Warning letter
BET Pharm LLC: warning letter of Nov 17, 2003
FDA warning letter UCM147830 · Cincinnati District Office
Key facts
| Reference number | UCM147830 |
|---|---|
| Company | BET Pharm LLC |
| Subject | Compounding Veterinary Drug/GMP for Finished Pharmaceuticals/Misbranded/Adulterated |
| Issue date | Nov 17, 2003 |
| Posted date | Nov 17, 2003 |
| Issuing office | Cincinnati District Office |
| Product type | Drugs |
| CFR sections cited | 201.115, 211.166, 211.188, 211.198, 211.67(a), 211.84(a), 211.100(a), 211.160(b), 211.165(a), 211.167(a), 211.196, 530 and 5 more |
| Country | 3 |
| Inspection city | Lexington |
| Inspection ZIP | 40511-1209 |
| Inspection start date | Jun 30, 2003 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: